Evidence map›Paper›PMID 34766561›Full record

Observational studyMedicine2021

SARS-CoV-2 could be spread through hospital medication dispensed to patients: A prospective observational study.

Santiago Grau, Olivia Ferrández, Daniel Echeverría-Esnal, Rafael Maldonado, Berta Puig, Aida Ramirez, Mireia Canal, Albert Montero, Cristina González, Milagros Herranz and 3 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Santiago GrauPharmacy Department, Hospital del Mar, Barcelona, Spain.ORCID 0000-0003-4975-8798
Olivia FerrándezPharmacy Department, Hospital del Mar, Barcelona, Spain.
Daniel Echeverría-EsnalPharmacy Department, Hospital del Mar, Barcelona, Spain.
Rafael MaldonadoLaboratory of Neuropharmacology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, PRBB, Barcelona, Spain.
Berta PuigMicrobiology Department, Laboratori de Referència de Catalunya, Barcelona, Spain.
Aida RamirezMicrobiology Department, Laboratori de Referència de Catalunya, Barcelona, Spain.
Mireia CanalMicrobiology Department, Laboratori de Referència de Catalunya, Barcelona, Spain.
Albert MonteroPharmacy Department, Hospital del Mar, Barcelona, Spain.
Cristina GonzálezEpidemiology and Evaluation Department, Parc de Salut Mar, Barcelona, Spain.
Milagros HerranzEpidemiology and Evaluation Department, Parc de Salut Mar, Barcelona, Spain.
Joan Ramon MasclansCritical Care Department, Hospital del Mar, Barcelona, Spain.
Juan Pablo HorcajadaInfectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Spain.
Eduardo PadillaMicrobiology Department, Laboratori de Referència de Catalunya, Barcelona, Spain.
Hospital Del Mar · ESUniversitat Autònoma de Barcelona · ESParc de Salut · ESUniversitat Pompeu Fabra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractOur objective was to analyze in vitro the persistence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in the packaging material of the drugs dispensed to hospital wards. Additionally, to evaluate if the protection with a double plastic bag prevents the contamination of the medication dispensed to an intensive care unit (ICU).On the first part, different materials containing different drugs within an ICU were sampled to confirm the lack of contamination by SARS-CoV-2. The confirmation of the virus was performed using real time reverse transcription polymerase chain reaction. As a control group, in the microbiology laboratory we inoculated the virus into the different surfaces containing the same drugs included in the first part. Samples were obtained with a sterile swab at 3, 6, 8, 10, 14, 21, and 30 days after inoculation and analyzed through real time reverse transcription polymerase chain reaction.None of the studied materials containing the drugs within an ICU was contaminated by SARS-CoV-2. In the second part, SARS-CoV-2 was found in all surfaces for up to 30 days.The use of double-bag unit-dose system to deliver medication in a pandemic seems effective to prevent the potential transmission of SARS-CoV-2. A striking SARS-CoV-2 RNA stability of up to 30 days was found in the surfaces containing the drugs.

Indexed as

Pharmaceutical PreparationsCOVID-19Disease OutbreaksDrug ContaminationHospitalsHumansIntensive Care UnitsReal-Time Polymerase Chain ReactionRNA, ViralSARS-CoV-2Pharmaceutical PreparationsRNA, Viral

Identifiers

PMID34766561
PMCPMC8589228
OpenAlexW3214246827

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.